Key result
Heparin-coated stents target reductions in stent thrombosis and bleeding complications in interventional cardiology.
Why the study?
Early stent implantation was associated with high thrombotic occlusion and bleeding complications from intensive anticoagulation, motivating strategies to reduce stent thrombogenicity.
Do heparin-coated stents reduce stent thrombosis and hemorrhagic complications?
Do heparin-coated stents reduce stent thrombosis and hemorrhagic complications?
This review discusses the preclinical and clinical evaluation of heparin-coated stents designed to reduce stent thrombosis and bleeding complications.
No takes yet. Share an insight, caveat, or question.
Heparin coating may lower early stent thrombosis; leaves open its net benefit versus modern dual antiplatelet regimens.
Kocsis et al. (2000) conducted a review in Stent thrombosis and hemorrhagic complications. Heparin-coated stents was evaluated. This review discusses preclinical evaluations and clinical studies of heparin-coated stents designed to reduce stent thrombosis and hemorrhagic complications in interventional cardiology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: